Variant report
Variant | esv1815292 |
---|---|
Chromosome Location | chr7:85493798-85525999 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:85522405..85523206-chr7:86098665..86099240,2 | MCF-7 | breast: | |
2 | chr7:85513282..85514931-chr7:85515657..85518081,2 | K562 | blood: | |
3 | chr7:85519420..85520975-chr7:86097643..86099272,2 | MCF-7 | breast: | |
4 | chr7:85513282..85514931-chr7:85515657..85518081,2 | K562 | blood: | |
5 | chr7:85518932..85520222-chr7:86098724..86099479,6 | MCF-7 | breast: | |
6 | chr7:85519463..85520587-chr7:86098657..86099580,4 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs376936460 | chr7:85495803-85495804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs190067749 | chr7:85495835-85495836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs12537524 | chr7:85495837-85495838 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs578075439 | chr7:85495861-85495862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs545468655 | chr7:85495880-85495881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs79451324 | chr7:85495917-85495918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs4613919 | chr7:85495955-85495956 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs543286231 | chr7:85495958-85495959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs561993308 | chr7:85495966-85495967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs4560725 | chr7:85495992-85495993 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs546980315 | chr7:85496020-85496021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565296743 | chr7:85496066-85496067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532768256 | chr7:85496076-85496077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs551035159 | chr7:85496105-85496106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs534614686 | chr7:85496106-85496107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs148379220 | chr7:85496119-85496120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs569667553 | chr7:85496129-85496130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs369488795 | chr7:85496163-85496164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs537637086 | chr7:85496178-85496179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs181287516 | chr7:85496190-85496191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs567948272 | chr7:85496194-85496195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs78588281 | chr7:85496209-85496210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs10264149 | chr7:85496236-85496237 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs184048801 | chr7:85496245-85496246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs149999246 | chr7:85496289-85496290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs557409578 | chr7:85496314-85496315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs575676090 | chr7:85496317-85496318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs61131740 | chr7:85496325-85496326 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs10264488 | chr7:85496340-85496341 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs376332646 | chr7:85496352-85496353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs552096145 | chr7:85496370-85496371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs188343277 | chr7:85496372-85496373 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs112205506 | chr7:85496381-85496382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs180989828 | chr7:85496461-85496462 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs4615498 | chr7:85496508-85496509 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs376625941 | chr7:85496521-85496522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs550998450 | chr7:85496579-85496580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs6979503 | chr7:85496583-85496584 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs181841567 | chr7:85503834-85503835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs144250213 | chr7:85503853-85503854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs569170642 | chr7:85503888-85503889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs185897307 | chr7:85503910-85503911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs548514351 | chr7:85503915-85503916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs567509160 | chr7:85504067-85504068 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs550272248 | chr7:85504089-85504090 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs12704182 | chr7:85504101-85504102 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs12704183 | chr7:85504117-85504118 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs188742990 | chr7:85504119-85504120 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs570487889 | chr7:85504126-85504127 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs181258718 | chr7:85504129-85504130 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Biliary cancer | 19435499 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Cancer | 21183584 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Williams-beuren syndrome | 16826523 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Wilms tumour | 19318497 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Schizophrenia | 17879154 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 16461572 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 20858243 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21611746 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:85495800-85496600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr7:85496000-85496400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr7:85503800-85504000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr7:85504000-85504800 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr7:85504200-85504800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr7:85504800-85505000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr7:85504800-85505200 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr7:85505200-85505400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr7:85505400-85505600 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr7:85513200-85514800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr7:85513400-85514600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
12 | chr7:85513600-85514600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
13 | chr7:85513800-85514200 | Enhancers | H1 Cell Line | embryonic stem cell |
14 | chr7:85513800-85514200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
15 | chr7:85513800-85514600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
16 | chr7:85516400-85516600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
17 | chr7:85517000-85517400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
18 | chr7:85522600-85523200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
19 | chr7:85525600-85527400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |